A detailed history of Fulton Bank, N.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fulton Bank, N.A. holds 3,065 shares of REGN stock, worth $2.07 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,065
Previous 3,372 9.1%
Holding current value
$2.07 Million
Previous $3.54 Million 38.4%
% of portfolio
0.18%
Previous 0.3%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 08, 2025

SELL
$701.85 - $1046.91 $215,467 - $321,401
-307 Reduced 9.1%
3,065 $2.18 Million
Q3 2024

Oct 07, 2024

SELL
$1024.09 - $1201.76 $563,249 - $660,968
-550 Reduced 14.02%
3,372 $3.54 Million
Q2 2024

Jul 09, 2024

BUY
$883.2 - $1071.19 $51,225 - $62,129
58 Added 1.5%
3,922 $4.12 Million
Q1 2024

Apr 10, 2024

BUY
$902.69 - $993.35 $100,198 - $110,261
111 Added 2.96%
3,864 $3.72 Million
Q4 2023

Jan 04, 2024

SELL
$775.18 - $881.7 $158,911 - $180,748
-205 Reduced 5.18%
3,753 $3.3 Million
Q3 2023

Oct 04, 2023

BUY
$692.45 - $844.37 $65,782 - $80,215
95 Added 2.46%
3,958 $3.26 Million
Q2 2023

Jul 06, 2023

SELL
$700.03 - $830.35 $275,111 - $326,327
-393 Reduced 9.23%
3,863 $2.78 Million
Q1 2023

Apr 06, 2023

BUY
$680.49 - $826.97 $172,163 - $209,223
253 Added 6.32%
4,256 $3.5 Million
Q4 2022

Jan 05, 2023

BUY
$705.89 - $766.39 $224,473 - $243,712
318 Added 8.63%
4,003 $2.89 Million
Q3 2022

Oct 04, 2022

BUY
$573.97 - $724.32 $297,316 - $375,197
518 Added 16.36%
3,685 $2.54 Million
Q2 2022

Jul 07, 2022

BUY
$548.35 - $738.84 $14,257 - $19,209
26 Added 0.83%
3,167 $1.87 Million
Q1 2022

Apr 05, 2022

BUY
$595.12 - $698.43 $57,131 - $67,049
96 Added 3.15%
3,141 $2.19 Million
Q4 2021

Jan 05, 2022

BUY
$543.48 - $670.97 $150,543 - $185,858
277 Added 10.01%
3,045 $1.92 Million
Q3 2021

Oct 05, 2021

BUY
$574.03 - $680.96 $47,070 - $55,838
82 Added 3.05%
2,768 $1.68 Million
Q2 2021

Jul 06, 2021

BUY
$472.8 - $558.54 $1.27 Million - $1.5 Million
2,686 New
2,686 $1.5 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Fulton Bank, N.A. Portfolio

Follow Fulton Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.